|
Title
|
|
|
|
Dendritic cells in the pathogenesis and treatment of human diseases : a Janus Bifrons?
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Dendritic cells (DCs) represent the bridging cell compartment between a variety of nonself antigens (i.e., microbial, cancer and vaccine antigens) and adaptive immunity, orchestrating the quality and potency of downstream immune responses. Because of the central role of DCs in the generation and regulation of immunity, the modulation of DC function in order to shape immune responses is gaining momentum. In this respect, recent advances in understanding DC biology, as well as the required molecular signals for induction of T-cell immunity, have spurred many experimental strategies to use DCs for therapeutic immunological approaches for infections and cancer. However, when DCs lose control over such protective responses by alterations in their number, phenotype and/or function undesired effects leading to allergy and autoimmune clinical manifestations may occur. Novel therapeutic approaches have been designed and currently evaluated in order to address DCs and silence these immunopathological processes. In this article we present recent concepts of DC biology and some medical implications in view of therapeutic opportunities. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Immunotherapy
| |
|
Publication
|
|
|
|
2011
| |
|
ISSN
|
|
|
|
1750-743X
1750-7448
| |
|
DOI
|
|
|
|
10.2217/IMT.11.110
| |
|
Volume/pages
|
|
|
|
3
:10
(2011)
, p. 1203-1222
| |
|
ISI
|
|
|
|
000296711800009
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|